Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence

Aboul-Enein, 2013, Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people, PLoS One, 8, e79649, 10.1371/journal.pone.0079649

Asgari, 2011, A population-based study of neuromyelitis optica in Caucasians, Neurology, 76, 1589, 10.1212/WNL.0b013e3182190f74

Bukhari, 2017, Incidence and prevalence of NMOSD in Australia and New Zealand, J. Neurol. Neurosurg. Psychiatry, 88, 632, 10.1136/jnnp-2016-314839

Cabre, 2009, Descriptive epidemiology of neuromyelitis optica in the Caribbean basin, Rev. Neurol. (Paris), 165, 676, 10.1016/j.neurol.2009.02.012

Cabre, 2001, MS and neuromyelitis optica in Martinique (French West Indies), Neurology, 56, 507, 10.1212/WNL.56.4.507

Cabrera-Gomez, 2009, An epidemiological study on neuromyelitis optica in Cuba, J. Neurol., 256, 35, 10.1007/s00415-009-0009-0

Cossburn, 2012, The prevalence of neuromyelitis optica in South East Wales, Eur. J. Neurol., 19, 655, 10.1111/j.1468-1331.2011.03529.x

Eskandarieh, S., Sahraian, M.A., Azimi, A.R., Moghadasi, A.N., Allahabadi, N.S., 2017. The prevalence, incidence and baseline characteristic of neuromyelitis optica in Tehran [abstract]. Mult. Scler. 23, 340. Presented at the 9th Congress of PACTRIMS, Bangkok, Thailand.

Etemadifar, 2014, An epidemiological study of neuromyelitis optica in Isfahan, Mult. Scler., 20, 1920, 10.1177/1352458514537699

Flanagan, 2016, Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum, Ann. Neurol., 79, 775, 10.1002/ana.24617

Fujihara, 2012, Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease, Clin. Exp. Neuroimmunol., 3, 58, 10.1111/j.1759-1961.2012.00030.x

Houzen, H., Kondo, K., Niino, M., 2016. Comparison of the prevalence and the clinical characteristics of NMOSD and MS in northern Japan [abstract]. Mult. Scler. 22(Suppl. 3), 868. Presented at the 32nd Congress of ECTRIMS, London, UK, 2016.

Houzen, 2012, Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan, J. Neurol. Sci., 323, 117, 10.1016/j.jns.2012.08.032

Jacob, 2013, The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom, J. Neurol., 260, 2134, 10.1007/s00415-013-6926-y

Kashipazha, 2015, A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran, Iran. J. Neurol., 14, 204

Lennon, 2004, A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis, Lancet, 364, 2106, 10.1016/S0140-6736(04)17551-X

Pandit, 2014, Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India, Mult. Scler., 20, 1651, 10.1177/1352458514521503

Penang Institute, 2016. Buku Data Asas Sosio-Ekonomi Negeri Pulau Pinang; Penang in Numbers 2014/2015. Report, Penang Institute, Malaysia (In Malay & English languages).

Sato, 2013, Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status, Brain Pathol., 23, 647, 10.1111/bpa.12087

Wingerchuk, 2015, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, 85, 177, 10.1212/WNL.0000000000001729